2023
Neurologic Complications of Babesiosis, United States, 2011–2021 - Volume 29, Number 6—June 2023 - Emerging Infectious Diseases journal - CDC
Locke S, O’Bryan J, Zubair A, Rethana M, Moffarah A, Krause P, Farhadian S. Neurologic Complications of Babesiosis, United States, 2011–2021 - Volume 29, Number 6—June 2023 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2023, 29: 1127-1135. PMID: 37209667, PMCID: PMC10202888, DOI: 10.3201/eid2906.221890.Peer-Reviewed Original ResearchConceptsNeurologic complicationsNeurologic symptomsRisk factorsYale-New Haven HospitalInfectious Diseases journal - CDCHigh-grade parasitemiaNeurologic risk factorsRange of symptomsAdult patientsRenal failureDiabetes mellitusFrequent symptomsHospital admissionImpaired consciousnessMedical recordsEndemic areasParasitic infectionsPatientsSymptomsIntraerythrocytic protozoaComplicationsBabesiosisNew HavenDeliriumMellitus
2015
Human babesiosis
Chen T, Mamoun C, Krause P. Human babesiosis. 2015, 1295-1301. DOI: 10.1017/cbo9781139855952.226.Peer-Reviewed Original ResearchHuman babesiosisB. microtiB. microti infectionHard-bodied ticksClustering of casesHuman granulocytic anaplasmosisAcute illnessRenal failureBlood transfusionMicroti infectionCommon causeBabesia duncaniEndemic areasEtiologic agentHuman infectionsHuman B. microti infectionIntraerythrocytic protozoaLyme diseaseBabesia microtiBabesia speciesDiseaseGranulocytic anaplasmosisBabesia infectionIntraerythrocytic parasitesInfection
2008
Human Babesiosis
Chen T, Krause P. Human Babesiosis. 2008, 1381-1388. DOI: 10.1017/cbo9780511722240.200.Peer-Reviewed Original ResearchHuman babesiosisB. microtiBabesia speciesB. microti infectionHard-bodied ticksClustering of casesHuman granulocytic anaplasmosisEastern North AmericaAcute illnessBlood transfusionRenal failureMicroti infectionCommon causeBabesia duncaniEndemic areasEtiologic agentHuman B. microti infectionBabesial infectionIntraerythrocytic protozoaBabesia microtiLyme diseaseDiseaseGranulocytic anaplasmosisIntraerythrocytic parasitesNorth America
1994
Quality Standard for the Treatment of Bacteremia
Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality Standard for the Treatment of Bacteremia. Infection Control And Hospital Epidemiology 1994, 15: 189-192. DOI: 10.2307/30145559.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsQuality Standards SubcommitteeInfectious Diseases SocietyTreatment of bacteremiaDiseases SocietyBlood culturesChart reviewersAdverse outcomesPediatric Infectious Diseases SocietyPlacebo-controlled trialPresence of bacteremiaSurgical Infection SocietySerious adverse outcomesAdministration of antibioticsAppropriate antimicrobial treatmentClinical Affairs CommitteeCase-control studyPositive blood culturesSpecific clinical indicationsAppropriate dosingHospitalized patientsRenal failureClinical trialsRisk factorsClinical indicationsHospital epidemiologyQuality standard for the treatment of bacteremia. The Infectious Diseases Society of America.
Gross P, Barrett T, Dellinger E, Krause P, Martone W, McGowan J, Sweet R, Wenzel R. Quality standard for the treatment of bacteremia. The Infectious Diseases Society of America. Infection Control And Hospital Epidemiology 1994, 15: 189-92. PMID: 8207177, DOI: 10.1086/646888.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsInfectious Diseases SocietyQuality Standards SubcommitteeTreatment of bacteremiaDiseases SocietyBlood culturesChart reviewersAdverse outcomesPediatric Infectious Diseases SocietyPlacebo-controlled trialPresence of bacteremiaSerious adverse outcomesSurgical Infection SocietyAdministration of antibioticsAppropriate antimicrobial treatmentClinical Affairs CommitteeCase-control studyPositive blood culturesSpecific clinical indicationsAppropriate dosingRenal failureHospitalized patientsProlonged hospitalizationRisk factorsClinical indicationsClinical trials